Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1901 of 5804
-
Gout showdown: which treatment strategy wins?
Disease control Recruiting nowThe TRUST study is a randomized, controlled multicenter study to evaluate the management of gout by comparing two commonly used treatment strategies for gout (TTT vs TTASx) to determine the most beneficial for a patient-centered gout outcomes, as well as relevant cardiovascular-m…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can extra phone support help smokers quit during lung screening?
Disease control Recruiting nowPrimary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives …
Phase: PHASE3 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New scan lights up hidden gut tumors
Diagnosis CompletedThis is a single-arm imaging study using DOTATOC peptide, labelled with the Gallium (68Ga) tracer.
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New Heat-Based treatment for hemorrhoids could be as effective as standard surgery
Disease control Recruiting nowSurgical treatment of grade II/III internal haemorrhoidal disease is indicated in the case of medical and/or instrumental treatment failure. Minimal invasive alternatives to haemorrhoidectomy have been introduced in the last decades to treat grade II/III haemorrhoids. Doppler-Gui…
Phase: NA • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Real-World data to reveal if lung cancer drug combo works equally across ages, races, and sexes
Knowledge-focused OngoingThis multi-year cohort study will assess the real-world safety and effectiveness of 1L treatment with cemiplimab in combination with platinum-doublet chemotherapy across advanced NSCLC patient subgroups defined by age, sex, race, and ethnicity. Patients will be retrospectively id…
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New tooth material could save Kids' teeth from root canals
Disease control OngoingStatement of the problem: Pulpotomy is the most popular technique for maintaining vitality and has a substantial impact on continuing root growth in vital, young permanent molars suffering from dental cavities. Biomimetic materials placement after performing pulp therapy is one…
Phase: PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for rare bone marrow diseases: drug tames immune attack
Disease control OngoingBackground: Immune bone marrow failure is a condition that occurs when a person s immune system attacks the cells of the bone marrow. This can lead to diseases including different types of anemias and blood cancers. Some of these diseases can be deadly. Better treatments are nee…
Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New injection aims to tame hormone chaos in kidney dialysis patients
Disease control CompletedThis is a multicenter, single-arm, long-term safety and tolerability trial. A total of 300 subjects with chronic kidney disease on hemodialysis are planned to be enrolled.
Phase: PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could cholesterol drugs fight blood cancer? small study tests idea
Disease control Recruiting nowPatients with clonal cytopenia of undetermined significance (CCUS) and lower-risk myelodysplastic syndromes (MDS) have a life expectancy of 5 to 10 years. Mortality in these patients results from progression of disease to higher-risk MDS or acute myeloid leukemia (AML) and cardio…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a smartphone app beat cervical cancer in rural kenya?
Knowledge-focused Recruiting nowIn the R21 phase of this project, investigators will: (1) work with key stakeholders and local and international developers to finalize the mSaada platform, building on the existing prototype to add patient and specimen tracking functionality; and (2) carry out a pilot to identif…
Phase: NA • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Nerve block may offer safer pain relief after major aortic surgery
Symptom relief Recruiting nowOpen abdominal aortic aneurysm repair (OR-AAA) is an operation associated with high morbidity, and has 30-day mortality rates of between 4 and 14%. Post-operative pain management represents a primary anesthetic focus. A better analgesia, in addition to being desirable for the pa…
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New cancer drug BR115 enters first human tests
Disease control TerminatedThis is a Phase I, multicenter, open-label, single-arm and first-in-human clinical study of BR115 for injection. The study objectives are to evaluate the safety, tolerability, pharmacokinetic profile, anti-tumor activity and immunogenicity of BR115 for injection in patients with …
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New study tests hormone combo to boost IVF success in adenomyosis patients
Disease control Recruiting nowThis randomized clinical trial aims to assess the comparative effectiveness of two distinct endometrial preparation protocols for frozen embryo transfer (FET) among women with adenomyosis undergoing IVF/ICSI. Specifically, it seeks to address the following key questions: 1. Does…
Phase: NA • Sponsor: Mỹ Đức Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Steroid shield: prednisone may protect liver during cancer radiation
Disease control Recruiting nowPatients on this study will self administer Prednisone for three days before starting Radiation Therapy (RT) and continue to take 60 mg/day during the first three fractions of RT.
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Online body project aims to stop eating disorders before they start
Prevention OngoingEating disorders (EDs) are a group of illnesses associated with significant psychological and physiological consequences. Overall, only 20% of individuals with EDs receive treatment and treatment is effective for only about 25-35% for those who receive care. The development and i…
Phase: NA • Sponsor: Oslo University Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Herbal combo boosts h. pylori treatment, study finds
Disease control CompletedVonoprazan and high-dose amoxicillin dual therapy was used as a control group to evaluate the clinical efficiency and safety of Banxiaxiexin decoction combined with vonoprazan and high-dose amoxicillin dual therapy in the treatment of helicobacter pylori infection complicated wit…
Phase: PHASE3 • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Experimental drug offers hope for Tough-to-Treat amyloidosis
Disease control Recruiting nowThe goal of this study is to test the safety of drug, Belantamab Mafodotin, and see what effects (good and bad) it has on people who take it and have amyloidosis, and to determine the most effective dose of the drug. The study will have 2 phases (parts). The first phase of the s…
Phase: PHASE1, PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
VR headset could boost alcohol recovery
Disease control Recruiting nowThe goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering alcoh…
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New scan could sharpen stomach cancer staging
Diagnosis CompletedTwenty (n=20) patients with gastric cancer or gastro-esophageal junctional cancer will undergo FAPI PET/CTs in addition to routing diagnostic workup (including FDG PET/CT) at primary staging and restaging. The FAPI PET/CT results will be compared to conventional imaging (includi…
Phase: PHASE2 • Sponsor: Aalborg University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Poop pills: does donor selection make or break IBS treatment?
Symptom relief OngoingFive hundred patients are randomized 1:1:1:1 into placebo (own feces), or receiving 90 g fecal transplant from donor A, donor B or donor C. The fecal transplant is administered to the distal duodenum via the working channel of a gastroscope. The patients shall complete 6 question…
Phase: NA • Sponsor: Haukeland University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC